Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis

Rahul Rajeev, MBBS; Kiran K. Turaga, MD

Disclosures

Cancer Control. 2016;23(1):36-46. 

In This Article

Conclusions

Advances in diagnostic and therapeutic techniques, including surgical cytoreductive techniques, have demonstrated significant survival gains in patients with peritoneal disease. Such improvements must happen within the changing landscape of cancer care. In addition, advances in immunotherapy and personalized therapies hold significant promise, as do techniques in genetic sequencing that may predict and potentially prevent disease rather than treat it. Collaboration and partnerships with the community and our patients are critically important for significant strides to be made. Although hyperthermic intraperitoneal chemotherapy can be used for the management of various types of histologies, high-level evidence is still lacking for its use in patients with peritoneal carcinomatosis.

processing....